Donating plasma while sick puts both you and the people who eventually receive plasma-derived products at risk, which is why donation centers screen every donor before every session and will turn you away if you show signs of illness. If you manage to slip through screening while harboring an infection, your body loses proteins and fluids it needs to fight off whatever is making you sick, and the collected plasma may contain pathogens or inflammatory markers that compromise its quality. The safeguards in place are multilayered, but they depend on honesty during the pre-donation questionnaire, and understanding why those questions matter can change how you approach your next appointment.
What Screening Looks Like Before Every Donation
Every plasma donation center conducts a health screening before collection begins. This typically involves a questionnaire about recent illness, medications, and risk behaviors, followed by a brief physical check of your temperature, pulse, blood pressure, and hemoglobin level. If your temperature is elevated or you report symptoms like a cough, sore throat, fever, or gastrointestinal distress, you are deferred on the spot. The goal is to catch active infections before they enter the plasma supply.
The donor history questionnaire is a surprisingly important safety tool. A German study comparing blood donors who tested positive for HIV or hepatitis C against reported cases in the general population found that improved screening for specific risk factors could have prevented a meaningful share of infected donations from being collected in the first place. For example, better recording of certain risk exposures could have prevented acceptance of roughly half of HIV-infected donors and about one in six HCV-infected donors.1PubMed Central. Which Infectious Blood Donors Could Be Identified by the Donor History Questionnaire? The questionnaire is not foolproof, but it catches a lot when donors answer honestly.
Beyond the questionnaire, your hemoglobin is checked to make sure your blood can handle the loss. This is typically done with a fingerstick, though research has shown that fingerstick readings can diverge from venous hemoglobin, particularly in women with lower iron stores. In one study, female donors with absent iron stores who passed the fingerstick cutoff often had venous hemoglobin below the acceptable threshold.2PubMed Central. The difference between fingerstick and venous hemoglobin and hematocrit varies by sex and iron stores This matters because if you are sick and your body is already under stress, marginal hemoglobin levels become a bigger problem.
What Happens to Your Body If You Donate While Sick
Plasma is rich in proteins, including antibodies (immunoglobulins), clotting factors, and albumin. When you are healthy, your liver replaces these proteins within a day or two. When you are fighting an infection, your immune system is already consuming resources at a higher rate than usual. Removing a portion of your plasma during an active illness means pulling away antibodies and other immune proteins your body is actively using.
The result is that your illness may last longer or feel worse. Your body has to simultaneously replenish the donated plasma and fight whatever infection you have. Classic research on plasma protein dynamics showed that circulating protein levels can drop substantially under physiological stress, with plasma volume itself shrinking to compensate. Under normal conditions, a dynamic equilibrium between tissue proteins and plasma proteins keeps things balanced, but donating plasma tips that balance in the wrong direction when your body is already depleted.3PubMed Central. Blood Plasma Protein Given by Vein Utilized in Body Metabolism
There is also the question of how you feel during the donation itself. Plasmapheresis involves sitting in a chair for 45 minutes to over an hour while blood is drawn, separated, and the non-plasma components returned to you. If you are already dehydrated, feverish, or fatigued from illness, the fluid shifts involved make you more susceptible to lightheadedness, nausea, and fainting. Vasovagal reactions, where your blood pressure drops and you feel faint or actually pass out, are the most common adverse event during plasma donation, and they are more likely when your body is already compromised.
A study examining donor health among frequent U.S. source plasma donors found that cough, cold, occasional fatigue, and sore throat were among the most commonly reported health conditions, though the study found no clear difference in these symptoms based on donation frequency or sex.4Transfusion. Effects of donation frequency on U.S. source plasma donor health That finding tells us something important: many donors show up with mild respiratory symptoms. Whether those donors were turned away or donated anyway is a separate question, but it underscores how common it is for people to feel “a little off” and still consider donating.
How Illness Affects the Plasma You Donate
Plasma from a sick donor is not the same as plasma from a healthy one. Active infections trigger an inflammatory response that can flood your blood with cytokines, chemokines, and other signaling molecules. These inflammatory markers can alter the composition of the plasma in ways that matter for manufacturing.
Research on plasma quality has been most detailed in the context of COVID-19 convalescent plasma, where the question of “how recovered is recovered enough” was studied closely. One study examining convalescent plasma from recovered COVID-19 donors found that most inflammatory cytokines were either undetectable or at very low levels, confirming that the donors had genuinely recovered. Several markers including IFN-γ, IL-6, TNF-α, and more than a dozen others were below the limit of detection, while only a few showed a small, non-significant increase compared to pre-pandemic controls.5PLoS ONE. Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality The takeaway is that recovered donors produce clean plasma, but donors still in the thick of an illness would not show this profile.
A separate study measured a broad panel of cytokines in plasma from recovered COVID-19 blood donors and compared them to controls who had never been infected. It found no statistically significant differences in any of the cytokines measured.6Transfusion Medicine and Hemotherapy. Cytokine, Anti-SARS-CoV-2 Antibody, and Neutralizing Antibody Levels in Conventional Blood Donors Who Have Recovered from COVID-19 Again, the emphasis is on “recovered.” Full recovery resets the inflammatory picture. Plasma collected during active illness, by contrast, would carry an inflammatory signature that could degrade the quality of products manufactured from it and potentially trigger adverse reactions in recipients.
The Safety Net That Protects Recipients
Even with screening, some infected donations inevitably enter the supply. This is particularly true during the “window period” of an infection, the days or weeks after someone contracts a virus but before it is detectable by testing or symptoms appear. The plasma industry has built multiple overlapping safety layers specifically because no single screening method can catch everything.
Before plasma enters large manufacturing pools, donations are grouped into small batches and tested using nucleic acid amplification technology, which detects viral genetic material directly. In Europe, testing plasma pools for hepatitis C RNA has been mandatory. Any individual donation that tests positive is discarded before it reaches the larger pool. The manufacturing pool itself, which can be 2,000 liters or more, then undergoes additional processing steps designed to inactivate or remove viruses.7PubMed. Reducing the risk of infection from plasma products: specific preventative strategies
The most widely used viral inactivation method is solvent/detergent treatment, which destroys all lipid-enveloped viruses, a category that includes HIV, hepatitis B, and hepatitis C. The process has been refined over decades and can now be combined with prion-reduction steps. Modern solvent/detergent treatment reduces abnormal prion protein by more than five log steps while still preserving the functional proteins in the plasma. For non-enveloped viruses like hepatitis A and parvovirus B19, the strategy relies on dilution across the large pool and neutralization by antibodies already present in the pooled plasma.8Transfusion Medicine and Hemotherapy. The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma
Heat treatment (pasteurization) and nanofiltration add further layers. Because of this combination of overlapping strategies, transmission of HIV, hepatitis B, and hepatitis C through plasma products has become very rare in countries with modern blood safety systems.7PubMed. Reducing the risk of infection from plasma products: specific preventative strategies That said, “very rare” is not zero, and these safety steps work best when the viral load entering the pool is low to begin with. That is the whole point of screening donors before collection rather than relying solely on post-collection processing.
When the System Fails
Historical incidents illustrate why donor screening and honest self-reporting are not optional courtesies. A study published in The Lancet examined HIV-positive paid plasma donors and recovered frozen plasma from nine of them. Seven of those nine also tested positive for hepatitis C. None reported injecting drug use. The authors concluded that these donors were likely infected with multiple blood-borne diseases during the plasmapheresis process itself, pointing to contaminated equipment or procedures at the collection site.9The Lancet. Commercial plasmapheresis and risk of blood-borne diseases
This case is from an era with weaker safety protocols and is not representative of modern collection standards, but it highlights a fundamental vulnerability: every safety system is only as strong as its weakest link. Today, single-use disposable equipment has eliminated the cross-contamination risk described in that study, and nucleic acid testing catches most window-period infections. But the donor’s own honesty during screening remains the first and arguably most important barrier. If you know you are sick, saying so keeps a potentially compromised unit from ever entering the pipeline.
How Long to Wait After Being Sick
Different illnesses carry different deferral periods. For a common cold or mild respiratory infection, most centers ask you to wait until your symptoms have fully resolved. For anything requiring antibiotics, many centers want you to finish your course of medication and be symptom-free for a set number of days, often 72 hours to a week depending on the condition and the center’s policies.
For more serious infections, the wait is longer. The most thoroughly studied example is COVID-19. A study of convalescent plasma donors recommended that optimal donation happen at least 28 days after symptom onset, with donors having been symptom-free for more than two weeks before collection. That timing was tied not just to safety but to quality: donors who had experienced fever lasting longer than three days or temperatures above 38.5°C were more likely to have developed sufficiently high antibody levels to make their plasma therapeutically useful.10PubMed Central. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation
For blood-borne infections like HIV, hepatitis B, or hepatitis C, the deferral is permanent. You will not be allowed to donate plasma again. For other conditions, such as mononucleosis, the flu, or bacterial infections, the deferral is temporary but varies by center. If you are unsure whether your recent illness disqualifies you, calling the center before you go saves everyone time.
The “I Feel Fine” Gray Zone
The trickiest situation is not the person with an obvious fever or hacking cough. It is the person who feels mostly fine but has a lingering sniffle, mild fatigue, or the tail end of a cold. These borderline cases are where most real-world judgment calls happen, and they are where donors are most tempted to fudge their answers on the questionnaire.
There are a few things worth keeping in mind here. First, many mild infections are at their most contagious before symptoms fully appear, so “I’m almost over it” does not mean you are not shedding virus. Second, even mild residual illness puts your body in a state where the fluid and protein loss from plasmapheresis is harder to recover from. Third, the pre-donation vitals check is not designed to catch subtle illness. Your temperature might be normal, your pulse might be fine, and your hemoglobin might pass, but that does not mean your immune system is not still actively fighting something.
The practical advice is straightforward: if you have had any symptoms in the past few days, wait. Plasma centers operate on tight schedules and depend on repeat donors, so there is real social pressure to keep your appointment. But skipping one session to recover fully is better for your health and produces better plasma than pushing through while your body is still clearing an infection. Centers would rather defer you today and see you healthy next week than collect a unit that might not meet quality standards or leave you feeling terrible for days afterward.
Medications, Vaccines, and Other Deferrals People Confuse with Illness
It is worth distinguishing between being sick and taking something that temporarily disqualifies you. Certain medications cause automatic deferral not because you are ill but because the drug itself could be harmful if it ended up in a recipient’s plasma. Isotretinoin (used for acne) and finasteride (used for hair loss) are classic examples of medications that require deferral periods ranging from weeks to months after your last dose, even if you feel perfectly healthy.
Vaccines are another common source of confusion. Live-attenuated vaccines, such as the measles-mumps-rubella or varicella vaccines, typically require a waiting period because the weakened virus could theoretically be present in your blood. Inactivated vaccines and mRNA vaccines generally have shorter or no deferral periods, though policies vary by center and by country. Getting a flu shot, for instance, does not usually require any waiting period unless you develop symptoms afterward.
The common thread is that deferral rules exist to protect both the plasma supply and the donor. Whether the reason is an active cold, a recent vaccine, or a medication you are taking, the goal is the same: collect plasma only when the donor’s body is in a stable, healthy baseline state. If you are unsure about a specific medication or vaccine, most centers have a medical director or nurse on staff who can give you a definitive answer before you go through the trouble of showing up and getting turned away at the screening stage.
Why Paid Donors Face a Unique Tension
In many countries, plasma donors are compensated financially, which creates an incentive structure that does not exist for volunteer whole-blood donors. When you are being paid per visit, the temptation to donate even when you feel under the weather is real. Rent is due, and skipping a session means less money that week.
This tension is not hypothetical. The plasma industry relies heavily on repeat donors who come in frequently, sometimes twice a week. Research on frequent U.S. source plasma donors documented that common symptoms like cough, cold, and sore throat were prevalent in the donor population, though without a clear link to donation frequency itself.4Transfusion. Effects of donation frequency on U.S. source plasma donor health The question of whether those donors reported these symptoms before donating or pushed through them is harder to study, but anyone who has sat in a plasma center waiting room during cold season can tell you the answer is not always reassuring.
The financial incentive does not make paid donation inherently unsafe. Modern screening and pathogen-reduction steps exist precisely because the system accounts for human behavior. But it does mean that the burden of honest self-reporting falls disproportionately on people who can least afford to skip a session, and that is a systemic tension the industry has never fully resolved.